The importance of bone marrow examination in determining complete response to therapy in patients with multiple myeloma
AUTOR(ES)
Chee, Cheng E.
FONTE
American Society of Hematology
RESUMO
The current definition of complete response in multiple myeloma includes a requirement for a bone marrow (BM) examination showing less than 5% plasma cells in addition to negative serum and urine immunofixation. There have been suggestions to eliminate the need for BM examinations when defining complete response. We evaluated 92 patients with multiple myeloma who achieved negative immunofixation in the serum and urine after therapy and found that 14% had BM plasma cells more than or equal to 5%. Adding a requirement for normalization of the serum-free light chain ratio to negative immunofixation studies did not negate the need for BM studies; 10% with a normal serum-free light chain ratio had BM plasma cells more than or equal to 5%. We also found that, on achieving immunofixation-negative status, patients with less than 5% plasma cells in the BM had improved overall survival compared with those with 5% or more BM plasma cells (6.2 years vs 2.3 years, respectively; P = .01).
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2756122Documentos Relacionados
- Effect of thalidomide on bone marrow angiogenesis in multiple myeloma patients
- Multiple myeloma with bone marrow extracellular crystal deposition
- Identification of malignant plasma cell precursors in the bone marrow of multiple myeloma.
- Bone Marrow Depression after Drug Therapy in Patients with Systemic Lupus Erythematosus
- Pseudohyperphosphataemia in patients with multiple myeloma.
